Poster Hall Hours

Tuesday, May 10, 2016
3:00 pm - 6:30 pm

Wednesday, May 11, 2016
10:00 am - 6:30 pm

Thursday, May 12, 2016
10:30 am - 2:00 pm

For more information on how Informa manages and shares your personal data please see our Privacy Policy

FILL OUT THE FORM BELOW TO REGISTER FOR THE WEBINAR:

*This also covers the processing of my personal data provided above for these purposes, including profile building to better tailor the communication to my personal interests based on my previous and predicted choices.  You can withdraw your consent at any time with effect for the future. This does not affect the lawfulness of the processing up to the time of withdrawal. Furthermore, you have the right to object to the processing of your personal data for direct marketing purposes at any time. This includes profiling to the extent that it is related to such direct marketing.  Further information on the processing of personal data can be found in the  Sartorius Privacy Notice

September 15th | 3:00PM CET | 9:00AM EST


Rok Sekirnik

Head of Process Development, mRNA/pDNA 

Sartorius BIA Separations 

Chromatography in mRNA Production: From Analytics to Purification

The recently demonstrated efficacy of mRNA-based Covid-19 vaccines has shown the promise of this therapeutic format, but also highlighted the need for higher efficiency of mRNA production to meet enormous needs for global vaccine supply. The production process typically involves 10-15 steps including plasmid production, plasmid linearization, an in vitro transcription (IVT) reaction, mRNA purification, and lipid nanoparticle (LNP) production. This webinar will discuss the versatility of chromatography as applied to mRNA production, starting with the purification of the key raw material (plasmid DNA) to final polishing of mRNA drug substance. Utilizing multiple attributes of mRNA (charge, hydrophobicity, size, polyadenylation) and suitable design of chromatographic supports, chromatography can be applied to increase yield and purity at preparative scale for selective mRNA capture (by affinity or charge) and removal of key contaminants (e.g. dsRNA). Compared to traditional analytical approaches, chromatography can also be used to increase the throughput and information output of analytical testing by simultaneously determining mRNA, NTP, capping reagent content throughout the process (including during IVT) and monitoring of critical quality attributes (e.g. capping efficiency, dsRNA).

Abstract

Speaker

SPONSORED BY: